A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC).
Phase of Trial: Phase II
Latest Information Update: 24 May 2013
At a glance
- Drugs Prednisone (Primary) ; Satraplatin (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 09 Apr 2013 Planned end date changed from 1 Jan 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2012 Actual patient number (24) added as reported by ClinicalTrials.gov.